1. ISLHD Health Libraries
  2. ISLHD Health Libraries
  3. Research publications from current and former ISLHD staff.
Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/6294
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFacon Ten
dc.contributor.authorDimopoulos MAen
dc.contributor.authorLeleu XPen
dc.contributor.authorBeksac Men
dc.contributor.authorPour Len
dc.contributor.authorHájek Ren
dc.contributor.authorLiu Zen
dc.contributor.authorMinarik Jen
dc.contributor.authorMoreau Pen
dc.contributor.authorRomejko-Jarosinska Jen
dc.contributor.authorSpicka Ien
dc.contributor.authorVorobyev VIen
dc.contributor.authorBesemer Ben
dc.contributor.authorIshida Ten
dc.contributor.authorJanowski Wen
dc.contributor.authorKalayoglu-Besisik Sen
dc.contributor.authorParmar Gen
dc.contributor.authorRobak Pen
dc.contributor.authorZamagni Een
dc.contributor.authorGoldschmidt Hen
dc.contributor.authorMartin TGen
dc.contributor.authorManier Sen
dc.contributor.authorMohty Men
dc.contributor.authorOprea Cen
dc.contributor.authorBrégeault MFen
dc.contributor.authorMacé Sen
dc.contributor.authorBerthou Cen
dc.contributor.authorBregman Den
dc.contributor.authorKlippel Zen
dc.contributor.authorOrlowski RZen
dc.contributor.authorIMROZ Study Groupen
dc.date.accessioned2024-10-31T01:07:04Z-
dc.date.available2024-10-31T01:07:04Z-
dc.date.issued2024-10-31-
dc.identifier.citationN Engl J Med. 2024 Oct 31;391(17):1597-1609. doi: 10.1056/NEJMoa2400712. Epub 2024 Jun 3.en
dc.identifier.urihttps://islhd.intersearch.com.au/islhdjspui/handle/1/6294-
dc.subjectMyeloma-
dc.titleIsatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myelomaen
dc.identifier.journaltitleN Engl J Meden
dc.identifier.doi10.1056/NEJMoa2400712en
dc.contributor.islhdParmar, Gurdeepen
Appears in Collections:Research publications from current and former ISLHD staff.

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.